Inflammatory peptides at the beginning of hemodialysis in asymptomatic patients treated or not with angiotensin I-converting inhibitors.
Marceau
F
F
Brochu
S
S
Pelletier
I
I
Drapeau
G
G
Adam
A
A
Lebel
M
M
D000706:Anaphylatoxins / Q000032:analysis*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001920:Bradykinin / Q000097:blood*; D015926:Complement C3a / Q000032:analysis; D015936:Complement C5a / Q000032:analysis; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis
D000706:Anaphylatoxins; D000806:Angiotensin-Converting Enzyme Inhibitors; D015926:Complement C3a; D015936:Complement C5a; D001920:Bradykinin